Discordant Pneumonia Diagnosis From Presentation to Discharge Common
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 5, 2024 -- Discordant diagnoses from initial presentation to discharge occur in more than half of patients hospitalized and treated for pneumonia, according to a study published online Aug. 6 in the Annals of Internal Medicine.
Barbara E. Jones, M.D., from the University of Utah and Salt Lake City VA Healthcare System, and colleagues examined the evolution of pneumonia diagnoses among patients hospitalized from the emergency department in a retrospective nationwide cohort study conducted at 118 U.S. Veterans Affairs medical centers.
The researchers found that 13.3 percent of the 2,383,899 hospitalizations received an initial or discharge diagnosis and treatment of pneumonia; 9.1 and 10.0 percent received an initial and a discharge diagnosis, respectively. In 57 percent of patients, there were discordances seen between initial and discharge diagnoses. Thirty-three percent of those discharged with pneumonia diagnosis and positive initial chest image lacked an initial diagnosis. Thirty-six percent of those discharged initially lacked a discharge diagnosis and 21 percent did not have positive initial chest imaging. Uncertainty was often expressed in clinical notes: 58 and 48 percent in emergency department and at discharge, respectively. Greater uncertainty was seen for patients with discordant diagnoses, and they received more additional treatments; compared with concordant patients, only those lacking an initial pneumonia diagnosis had higher 30-day mortality (14.4 versus 10.6 percent).
"Our study suggests that diagnostic discordance, uncertainty, and treatment ambiguity are common features of clinical care for patients hospitalized with pneumonia, with important bearings on patient care and outcomes," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-06 07:15
Read more
- Long-Term Complications After Prostate Cancer Treatment Not Uncommon
- New Alzheimer's prevention trial receives $74.5 million NIH grant
- Prepping for Colonoscopy? An Expert Offers Tips to Make Things Easier
- AHA: Half of U.S. Adults Are Eligible for Treatment With Semaglutide
- ChemoRT Then Immunochemotherapy Then Surgery Promising in Unresectable Esophageal Cancer
- Weight Loss Meds Help Stroke Survivors Prevent Stroke Recurrence, Death
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions